USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Adienne Pharma &biotech Sa

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).

The verdict

According to USPTO PatentsView, Adienne ranks #22,127 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,127
of 50,000 US assignees by volume
Top 64%
by Innovation Score (30.8/100)
13.3
avg claims per patent
-43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22127 · Foreign Corporation #22,127 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,127/50,000
  • PHOTO-FINISH ABLEREX
  • CPC-NARROW A61J · 9 areas
  • INNOV-THIN 30.8/100
  • CLAIMS-RICH 13.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -43% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ablerex Electronics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Adienne

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Adienne's Innovation Score is 30.8/100 (top 64% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Adienne's grants concentrate

Adienne Pharma &biotech Sa is a focused PatentsView assignee: 9 CPC subclasses with 83.3% of grants classified under A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2021. By volume, Adienne sits between Ablerex Electronics Co., Ltd. and AF Chemicals, Llc.

Who files at Adienne's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Adienne holds 12 patents at rank #22,119, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Adienne

By rank, the assignees closest to #22,119 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Adienne's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Adienne, neither rank-band nor same-CPC leaders (those blocks stay above).

Adienne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 Top 64% higher than 36% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2018201920212022202320242025 1
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Adienne Pharma &biotech Sa patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 16.7%
2019 5 41.7%
2021 1 8.3%
2022 1 8.3%
2023 1 8.3%
2024 1 8.3%
2025partial year 1 8.3%

Where it ranks

Overall rank by patents

#22,127

of 50,000 tracked assignees

Innovation Score

30.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.